TrialClinical infectious diseases : an official publication of the Infectious Diseases Society of America2018

Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection in Patients at Increased Risk for Recurrence.

Dale N Gerding et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.